Neuehealth, INC 10-Q quarterly reports

NeueHealth reports improved operating income and Adjusted EBITDA for Q2 2025, but faces substantial doubt about its ability to continue as a going concern.

NeueHealth's Q1 2025 results reveal a net loss of $10.8 million and highlight substantial doubt about the company's ability to continue as a going concern, despite ongoing efforts to drive positive cash flow and a pending merger with NH Holdings 2025, Inc.

NeueHealth reports its Q3 2024 results, highlighting a third consecutive quarter of Adjusted EBITDA profitability driven by its NeueCare and NeueSolutions segments.

NeueHealth's Q2 2024 results show a net loss of $61.9 million, but the company has secured a $150 million term loan facility.

NeueHealth's first quarter results show a shift towards value-based care with growth in NeueCare and NeueSolutions segments, despite an overall revenue decrease.